Portable Amperometric Biosensor Enhanced with Enzyme-Ternary Nanocomposites for Prostate Cancer Biomarker Detection
2024

Portable Biosensor for Prostate Cancer Biomarker Detection

publication 10 minutes Evidence: high

Author Information

Author(s): Rajarathinam Thenmozhi, Jayaraman Sivaguru, Kim Chang-Seok, Lee Jaewon, Chang Seung-Cheol

Primary Institution: Pusan National University

Hypothesis

Can a portable amperometric biosensor effectively detect sarcosine as a biomarker for prostate cancer?

Conclusion

The developed biosensor demonstrated high sensitivity and a low detection limit for sarcosine, making it suitable for rapid prostate cancer screening.

Supporting Evidence

  • The biosensor exhibited a detection limit of 0.077 μM for sarcosine.
  • It showed a sensitivity of 8.09 μA mM−1 cm−2.
  • The biosensor was tested with human serum and synthetic urine samples.
  • The results indicated high selectivity against common interferents.
  • The biosensor maintained over 72% of its initial response after four weeks.
  • The calibration curve showed linearity between 1.0 and 100 μM sarcosine.
  • The biosensor's performance was validated with recovery ratios over 95%.

Takeaway

This study created a small device that can quickly check for a substance in urine that might indicate prostate cancer.

Methodology

The biosensor was developed using a chitosan-polyaniline-mesoporous carbon nanocomposite and tested for sarcosine detection in human serum and urine.

Limitations

The biosensor's performance may be affected by the presence of interfering substances in complex biological samples.

Statistical Information

P-Value

0.077

Confidence Interval

95.0%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/bios14120623

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication